Results 91 to 100 of about 843 (162)

Myotonic Dystrophy Type 1: Focus on the RNA Pathology and Therapy [PDF]

open access: yes, 2012
Andrie Koutsoulidou   +2 more
core   +2 more sources

Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells. [PDF]

open access: yesStem Cell Res Ther
Raaijmakers RHL   +7 more
europepmc   +1 more source

The Na+, K+-ATPase β1 subunit regulates epithelial tight junctions via MRCKα. [PDF]

open access: yesJCI Insight, 2021
Bai H   +8 more
europepmc   +1 more source

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1. [PDF]

open access: yesHum Mol Genet
Louis JM   +9 more
europepmc   +1 more source

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing. [PDF]

open access: yesInt J Mol Sci, 2022
Izzo M   +5 more
europepmc   +1 more source

AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action. [PDF]

open access: yesSci Adv
Cerro-Herreros E   +15 more
europepmc   +1 more source

MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model. [PDF]

open access: yesCells, 2021
Kwa MQ   +5 more
europepmc   +1 more source

Systematic approach to contextualize findings of flexible endoscopic evaluation of swallowing in neurogenic dysphagia- towards an integrated FEES report. [PDF]

open access: yesNeurol Res Pract
Dziewas R   +10 more
europepmc   +1 more source

Spatiotemporal control of actomyosin contractility by MRCKβ signaling drives phagocytosis. [PDF]

open access: yesJ Cell Biol, 2022
Zihni C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy